Pfizer Limited is the listed Indian arm of the American drugmaker. It markets prescription medicines and vaccines across a wide range of therapeutic areas in India.
Ownership and structure
Pfizer holds its India business through Pfizer Limited, a listed Indian subsidiary in which the promoter group owns 63.92 percent as of September 2026. Pfizer Limited is listed on the NSE and BSE under the symbol PFIZER.
What India does for Pfizer
India is a sales market for more than 150 Pfizer products across 15 therapeutic areas, supported by a manufacturing facility in Goa.
Pfizer's India business
Pfizer Limited was established in India in 1950. The company offers more than 150 products across 15 therapeutic areas.
Its portfolio is organised into four key business categories.
Key moves in India
- 1950: Pfizer entered the Indian market on 21 November through Dumex Limited.
- 1960: Pfizer opened a large plant at Thane near Mumbai.
- 1977: Pfizer Limited became a public limited company.
- 1992: Dumex Limited was amalgamated into Pfizer Limited.
- 2014: Pfizer Limited completed its merger with Wyeth Limited on 1 December.
- 2022: Pfizer Limited transferred its Upjohn business to Mylan with effect from 1 August.
- 2023: Pfizer Limited transferred its Thane business undertaking to Vidhi Research and Development LLP in February.
Where it operates
Pfizer runs its India business from Mumbai.
At a glance
- Home country: United States
- Global headquarters: New York
- Sector: Manufacturing & Supply Chains
- Business: Pharmaceuticals
- Role of India: Sales market, Manufacturing base
- India entity: Pfizer Limited
- Listed in India: Pfizer Limited (PFIZER)
- India head office: Mumbai
- India offices: Mumbai
- India headcount: Not available
- In India since: 1950
© 2026 The Narrative Republic
See every foreign company we track in our Foreign Companies in India directory.
